Promising immunotherapy for prostate cancer
Author:
Affiliation:
1. Division of Hematology and Oncology, Department of Medicine, University of Mississippi Cancer Center, Jackson, MS, USA
2. Department of Medical Oncology, GU section, Dana Farber Cancer Institute, Boston, MA, USA
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1406916
Reference77 articles.
1. Abiraterone and Increased Survival in Metastatic Prostate Cancer
2. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
3. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
4. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comprehensive analysis of novel cancer prediction genes and tumor microenvironment infiltration in colon cancer;Clinical and Translational Oncology;2023-04-04
2. Bone Health Management in the Continuum of Prostate Cancer Disease;Cancers;2022-09-02
3. Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer;Medical Science Monitor;2020-06-20
4. Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer;Journal of Clinical Laboratory Analysis;2020-06-02
5. Emerging Theranostic Silver and Gold Nanomaterials to Combat Prostate Cancer: A Systematic Review;Journal of Cluster Science;2019-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3